# 製藥與生技產業正反對川普政府的兩項提案。

*biotech · news · 2026-02-24 · STAT*

## Key points

- 製藥與生技產業反對川普提出的兩項降低Medicare藥價的提案。
- 這些提案將使Medicare藥價與其他富裕國家支付的價格保持一致。
- 計畫中的Medicare試點方案將是強制性的，且執行五年。
- 藥廠可能在提案最終確定後採取法律挑戰。

WASHINGTON — The pharmaceutical and biotech industries are pushing back against two Trump administration proposals that would test plans to lower drug prices in Medicare by aligning them with the prices paid in other rich countries. Their comments preview arguments that they might use in court against the Medicare pilot programs, which would be mandatory and run for five years. It’s too soon for drugmakers to mount legal challenges, because the pilots are still in the proposal phase, and drugmakers would have to wait until they’re finalized to file lawsuits. Advertisement

**Countries:** United States

[Read the full story on STAT](https://www.statnews.com/2026/02/24/pharma-opposition-medicare-drug-price-pilot-programs-strategy-emerges/)

---

Canonical: https://newsio.io/zh-TW/n/c95ca783-8287-49ec-bcc5-054d89a73287/
Summarized by Newsio from STAT. https://newsio.io/how-it-works